176 related articles for article (PubMed ID: 37127623)
1. Liquid-liquid phase separation throws novel insights into treatment strategies for skin cutaneous melanoma.
Liu J; Pei S; Zhang P; Jiang K; Luo B; Hou Z; Yao G; Tang J
BMC Cancer; 2023 May; 23(1):388. PubMed ID: 37127623
[TBL] [Abstract][Full Text] [Related]
2. The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature.
Zhou S; Sun Y; Chen T; Wang J; He J; Lyu J; Shen Y; Chen X; Yang R
Front Cell Dev Biol; 2021; 9():739594. PubMed ID: 34660598
[TBL] [Abstract][Full Text] [Related]
3. Necroptosis-related LncRNAs in skin cutaneous melanoma: evaluating prognosis, predicting immunity, and guiding therapy.
Liu J; Luo B; Zhang P; Jiang K; Hou Z; Cao X; Tang J
BMC Cancer; 2023 Aug; 23(1):752. PubMed ID: 37580654
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma.
Tian Q; Gao H; Zhao W; Zhou Y; Yang J
Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650
[TBL] [Abstract][Full Text] [Related]
5. DNA damage repair-related gene signature predicts prognosis and indicates immune cell infiltration landscape in skin cutaneous melanoma.
Liang L; Mai S; Mai G; Chen Y; Liu L
Front Endocrinol (Lausanne); 2022; 13():882431. PubMed ID: 35957812
[TBL] [Abstract][Full Text] [Related]
6. A Necroptosis-Related Gene Signature to Predict the Prognosis of Skin Cutaneous Melanoma.
Xie Y; Xu Z; Mei X; Shi W
Dis Markers; 2022; 2022():8232024. PubMed ID: 36438905
[TBL] [Abstract][Full Text] [Related]
7. Identification of molecular subtypes based on liquid-liquid phase separation and cross-talk with immunological phenotype in bladder cancer.
Sun L; Liu XP; Yan X; Wu S; Tang X; Chen C; Li G; Hu H; Wang D; Li S
Front Immunol; 2022; 13():1059568. PubMed ID: 36518754
[TBL] [Abstract][Full Text] [Related]
8. Development of an IFNγ response-related signature for predicting the survival of cutaneous melanoma.
Hu B; Wei Q; Li X; Ju M; Wang L; Zhou C; Chen L; Li Z; Wei M; He M; Zhao L
Cancer Med; 2020 Nov; 9(21):8186-8201. PubMed ID: 32902917
[TBL] [Abstract][Full Text] [Related]
9. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y
PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392
[TBL] [Abstract][Full Text] [Related]
10. An integrative multi-omics analysis based on liquid-liquid phase separation delineates distinct subtypes of lower-grade glioma and identifies a prognostic signature.
Zheng J; Wu Z; Qiu Y; Wang X; Jiang X
J Transl Med; 2022 Jan; 20(1):55. PubMed ID: 35093128
[TBL] [Abstract][Full Text] [Related]
11. Analysis of immune subtypes based on immunogenomic profiling identifies prognostic signature for cutaneous melanoma.
Hu B; Wei Q; Zhou C; Ju M; Wang L; Chen L; Li Z; Wei M; He M; Zhao L
Int Immunopharmacol; 2020 Dec; 89(Pt A):107162. PubMed ID: 33168410
[TBL] [Abstract][Full Text] [Related]
12. Coexpressed Genes That Promote the Infiltration of M2 Macrophages in Melanoma Can Evaluate the Prognosis and Immunotherapy Outcome.
Yan K; Wang Y; Lu Y; Yan Z
J Immunol Res; 2021; 2021():6664791. PubMed ID: 33748290
[TBL] [Abstract][Full Text] [Related]
13. Identification of a pyroptosis-associated long non-coding RNA signature for predicting the immune status and prognosis in skin cutaneous melanoma.
Wu L; Liu G; He YW; Chen R; Wu ZY
Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5597-5609. PubMed ID: 34604952
[TBL] [Abstract][Full Text] [Related]
14. Using Immune-Related lncRNA Signature for Prognosis and Response to Immunotherapy in Cutaneous Melanoma.
Xue L; Wu P; Zhao X; Jin X; Wang J; Shi Y; Yang X; She Y; Li Y; Li C
Int J Gen Med; 2021; 14():6463-6475. PubMed ID: 34675614
[TBL] [Abstract][Full Text] [Related]
15. Single-cell sequencing analysis related to sphingolipid metabolism guides immunotherapy and prognosis of skin cutaneous melanoma.
Ding Y; Zhao Z; Cai H; Zhou Y; Chen H; Bai Y; Liu Z; Liu S; Zhou W
Front Immunol; 2023; 14():1304466. PubMed ID: 38077400
[TBL] [Abstract][Full Text] [Related]
16. Identification of Lactate-Related Gene Signature for Prediction of Progression and Immunotherapeutic Response in Skin Cutaneous Melanoma.
Xie Y; Zhang J; Li M; Zhang Y; Li Q; Zheng Y; Lai W
Front Oncol; 2022; 12():818868. PubMed ID: 35265521
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value and Immunological Characteristics of a Novel RNA Binding Protein Signature in Cutaneous Melanoma.
Tian J; Ma C; Yang L; Sun Y; Zhang Y
Front Genet; 2021; 12():723796. PubMed ID: 34531901
[TBL] [Abstract][Full Text] [Related]
18. Significance of liquid-liquid phase separation (LLPS)-related genes in breast cancer: a multi-omics analysis.
Xie J; Chen L; Wu D; Liu S; Pei S; Tang Q; Wang Y; Ou M; Zhu Z; Ruan S; Wang M; Shi J
Aging (Albany NY); 2023 Jun; 15(12):5592-5610. PubMed ID: 37338518
[TBL] [Abstract][Full Text] [Related]
19. Low expression of endoplasmic reticulum stress-related gene SERP1 is associated with poor prognosis and immune infiltration in skin cutaneous melanoma.
Fan Y; Liang X; Yu D
Aging (Albany NY); 2021 Oct; 13(19):23036-23071. PubMed ID: 34613934
[TBL] [Abstract][Full Text] [Related]
20. Construction of Circadian Clock Signature for Tumor Microenvironment in Predicting Survival for Cutaneous Melanoma.
Zeng N; Xia Q; Li Y; Ma L; Cheng Y; Chen Y; Lu Q; Lu Z; Wu D; Luo D
Curr Pharm Des; 2022; 28(28):2349-2361. PubMed ID: 35927923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
